Molecule Holdings wins partial OSC cease-trade revocation to restructure secured debt, raise up to $300,000 in private placement
Reuters2026/09/01 01:33- Molecule received an Ontario Securities Commission partial revocation order on Aug. 28, 2026 to execute a secured-debt restructuring.
- Outstanding secured debt totals $2.5 million, including convertible secured debentures and a secured note, with 8%-12% interest terms.
- Plan settles $544,489.68 of principal, accrued interest, and a 10% penalty into shares at $0.015, capped at 9.99% ownership.
- Remaining $1.96 million becomes Amended Secured Debt at 12% interest, maturing three years from closing; junior interest paid in shares.
- Proposed non-brokered private placement targets up to 30,000,000 units at $0.01 for gross proceeds up to $300,000.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Global bond yields rise to highest level in two decades as oil prices and inflation fears rattle markets
Sonoro Provides Initial Assays from 50,000-Meter Drill Campaign at Cerro Caliche Project in Mexico
Sector Update: Energy
Strong demand for cardiac devices drives Medtronic (MDT.US) to exceed Q1 expectations and raise full-year guidance; invests $700 million to expand robotic surgery business.
Medical device manufacturer Medtronic reported better-than-expected results for the first quarter of fiscal year 2027 and raised its full-year guidance, betting on strong demand for its cardiac devices used in complex cardiovascular surgeries.
Crypto prices
More
